Acronym
SONODRUGS
Code
41R05608
Duration
01 November 2008 → 31 October 2013
Funding
European funding: framework programme
Promotor
Research disciplines
-
Natural sciences
- Medicinal and biomolecular chemistry
- Biochemistry and metabolism
- Molecular and cell biology
- Plant biology
- Systems biology
-
Medical and health sciences
- Biophysics
- Medical biochemistry and metabolism
- Molecular and cell biology
- Biophysics
- Medical biochemistry and metabolism
- Molecular and cell biology
- Biomarker discovery and evaluation
- Drug discovery and development
- Medicinal products
- Pharmaceutics
- Pharmacognosy and phytochemistry
- Pharmacology
- Pharmacotherapy
- Toxicology and toxinology
- Other pharmaceutical sciences
- Biophysics
- Medical biochemistry and metabolism
- Molecular and cell biology
-
Engineering and technology
- Chemical product design and formulation
- Biomaterials engineering
- Biological system engineering
- Biomaterials engineering
- Biomechanical engineering
- Other (bio)medical engineering
- Environmental engineering and biotechnology
- Industrial biotechnology
- Other biotechnology, bio-engineering and biosystem engineering
Keywords
nanomaterials
ultrasound
drug delivery
Project description
This project evaluates the potential of ultrasone energy (as clinically used in echography) for the targeted delivery of drugs formulated in nanoscopic carriers.